I'm torn on what to think here. NP and Co. got lam
Post# of 148109
So, with that as background, if they had good or great results on the interim, you'd think they'd have reflected that sentiment in the PR today.
On the other hand, if CytoDyn did release a super-positive PR, NP might fear that would be seen by the FDA as an attempt to use the good results to strong-arm them in a corner with the EUA decision.
Will it matter with the corrupt FDA doing their immuno-therapy trials with only BP treatments? The FDA is about as trustworthy as a love-child clone of nixon, trump and the clintons.